GREY:TSTIF - Post by User
Post by
tadigon May 29, 2017 9:59pm
251 Views
Post# 26298475
RR and acquisitions
RR and acquisitionsAfter digging into the former gigs of RR, he appears to have orchestrated a number of acquisitions with leading medical companies. He obviously brought this experience when bringing in Getinge, but I wonder if he had a plan all along... I think by holding back information, this is allowing TSO3 to grow without much scrutiny, preventing a company from taking them earlier. This way, the price is conservatively priced until critcal mass occurs.
Given RR's experience with endoscopes, there is obviously a master plan here. As with all things in life, it always takes longer than expected. But you can't deny that TSO3 has a product that people want. If you are in the market for a new low-temp sterilizer.. anything but sheer ignorance has you pulling for a Sterizone VP4. I wonder if FDA approval for the 80L surgery room sterilizer is soon to be submitted? The FDA would surely rubber stamp the new model, expanding the new classification created solely for TSO3's technology.
All things point to TSO3 growing organically and conservatively. As a shareholder, I prefer sustained increases in SP, and even the upshot from extended claims was a bit too much. I'm sure as more information gets released, we approach that $6 mark that analysts seem to be coalescing around.